Related Experiment Video
Updated: Apr 16, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
Concave microwell array-mediated three-dimensional tumor model for screening anticancer drug-loaded nanoparticles
AhRan Kang1, Hye In Seo2, Bong Geun Chung2
1NBIT, KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.
Abstract:
We investigated the effect of anticancer drug-loaded functional polymeric nanoparticles on drug resistance of three-dimensional (3D) breast tumor spheroids. 3D tumor models were built using concave microwells with different diameters (300-700μm) and nanoparticles were prepared using thermo-responsive poly(N-isopropylacrylamide) (PNIPAM)-co-acrylic acid (AA). Upon culturing with doxorubicin-loaded PNIPAM-co-AA nanoparticles for 96hours, the smallest tumor spheroids were extensively disrupted, resulting in a reduction in spheroid diameter. In contrast, the sizes of the largest tumor spheroids were not changed. Scanning electron microscopy revealed that the circular shape of 3D spheroids treated with doxorubicin-loaded PNIPAM-co-AA nanoparticles had collapsed severely. Cell viability assays also demonstrated that the largest tumor spheroids cultured with doxorubicin-loaded PNIPAM-co-AA nanoparticles were highly resistant to the anticancer drug. We confirmed that tight cell-cell contacts within largest tumor spheroids significantly improved the anticancer drug resistance. Therefore, this uniform-sized 3D breast tumor model could be a potentially powerful tool for anticancer drug screening applications.
From The Clinical Editor:
The battle against cancer is a big challenge. With new anti-cancer drugs being developed under the nanotechnology platform, there is a need to have a consistent and reliable testing system that mimics the in-vivo tumor scenario. The authors successfully designed a 3D tumor model using concave microwells to produce different tumor diameters. This will be of value for future drug screening.
Insights
Functional polymeric nanoparticles loaded with anticancer drugs show varying effects on 3D breast tumor spheroids. Smaller spheroids were disrupted, while larger ones exhibited drug resistance due to tight cell-cell contacts, highlighting a new drug screening model.
Area of Science:
- Nanotechnology
- Materials Science
- Biomedical Engineering
Background:
- Developing effective cancer therapies requires reliable in-vivo mimicking tumor models for drug screening.
- Nanotechnology offers novel platforms for targeted drug delivery and cancer treatment.
Purpose of the Study:
- To investigate the impact of anticancer drug-loaded functional polymeric nanoparticles on drug resistance in 3D breast tumor spheroids.
- To evaluate the utility of a 3D tumor model for anticancer drug screening.
Main Methods:
- Fabrication of 3D breast tumor spheroids using concave microwells of varying diameters (300-700μm).
- Preparation of thermo-responsive poly(N-isopropylacrylamide) (PNIPAM)-co-acrylic acid (AA) nanoparticles loaded with doxorubicin.
- Treatment of 3D tumor spheroids with drug-loaded nanoparticles and subsequent analysis of spheroid disruption, size changes, and cell viability.
Main Results:
- Doxorubicin-loaded nanoparticles significantly disrupted smaller 3D tumor spheroids.
- Larger 3D tumor spheroids exhibited resistance to the anticancer drug, showing no significant size reduction.
- Scanning electron microscopy confirmed severe collapse in treated spheroid shapes.
- Cell viability assays indicated high drug resistance in larger spheroids, attributed to tight cell-cell contacts.
Conclusions:
- Tight cell-cell contacts in larger 3D breast tumor spheroids significantly enhance anticancer drug resistance.
- Uniform-sized 3D breast tumor models are a promising tool for effective anticancer drug screening applications.

